Overview

All Trans Retinoic Acid Combined with Toripalimab+Chemotherapy for Locally Advanced Inoperable or Metastatic Triple Negative Breast Cancera Multi-center, Multi-cohort Phase II Trial

Status:
RECRUITING
Trial end date:
2029-09-01
Target enrollment:
Participant gender:
Summary
All trans retinoic acid Combined with Toripalimab+Chemotherapy for Locally Advanced inoperable or Metastatic Triple Negative Breast Cancera multi-center, multi-cohort phase II trial
Phase:
PHASE2
Details
Lead Sponsor:
Fudan University